ES2074966A1 - Process for obtaining 3-2-[4-(6-fluoro-benzo[d]isoxazol-3- yl)-piperidin-1-yl]-ethyl-2-methyl-6,7,8,9-tetrahydro-4H- pyrido-[1,2-a]pyrimidine-4-one - Google Patents

Process for obtaining 3-2-[4-(6-fluoro-benzo[d]isoxazol-3- yl)-piperidin-1-yl]-ethyl-2-methyl-6,7,8,9-tetrahydro-4H- pyrido-[1,2-a]pyrimidine-4-one

Info

Publication number
ES2074966A1
ES2074966A1 ES09400252A ES9400252A ES2074966A1 ES 2074966 A1 ES2074966 A1 ES 2074966A1 ES 09400252 A ES09400252 A ES 09400252A ES 9400252 A ES9400252 A ES 9400252A ES 2074966 A1 ES2074966 A1 ES 2074966A1
Authority
ES
Spain
Prior art keywords
tetrahydro
pyrimidine
methyl
isoxazol
pyrido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09400252A
Other languages
Spanish (es)
Other versions
ES2074966B1 (en
Inventor
Barjoan Pere Dalmases
Olondriz Francisco Marquillas
Clotet Joan Huguet
Rovira Anna Bosch
CASTILLO NIETO Juan DEL
Ges Jose Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES09400252A priority Critical patent/ES2074966B1/en
Priority to GR950100035A priority patent/GR1002344B/en
Priority to SK156-95A priority patent/SK281752B6/en
Priority to CZ1995329A priority patent/CZ286398B6/en
Priority to IS4259A priority patent/IS1766B/en
Priority to EG11595A priority patent/EG20877A/en
Priority to PT101654A priority patent/PT101654B/en
Priority to NO950501A priority patent/NO306022B1/en
Priority to HU9500418A priority patent/HU222110B1/en
Priority to FI950579A priority patent/FI110000B/en
Priority to PL95307200A priority patent/PL181420B1/en
Priority to AT0024995A priority patent/AT405401B/en
Priority to RU95101859/04A priority patent/RU2123004C1/en
Priority to KR1019950002516A priority patent/KR100221108B1/en
Publication of ES2074966A1 publication Critical patent/ES2074966A1/en
Application granted granted Critical
Publication of ES2074966B1 publication Critical patent/ES2074966B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Process for obtaining 3-2-[4-(6-fluoro-benzo[d]isoxazol-3- yl)-piperidin-1-yl]-ethyl-2-methyl-6,7,8,9-tetrahydro-4H- pyrido-[1,2-a]pyrimidine-4-one The process comprises reacting 3-(2-aminoethyl)-2-methyl- 6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-4-one of formula II with compounds of general formula III where Y and Z are projecting groups which may be the same or different such as halogen or an alkyl or aryl sulphonyloxy group in the presence of an appropriate solvent and base to provide 3-2-[4-6-fluoro- benzo[d]isoxazol-3-yl)piperidin-I-yl]-ethyl-2-methyl- 6,7,8,9-tetrahydro-4Hpyrido [1,2-a] pyrimidine-4-one of general formula I. The said compound has pharmaceutical applications on account of its antipsychotic properties. Products of formulae II and III which are necessary for the performance of this invention are also claimed.
ES09400252A 1994-02-11 1994-02-11 PROCEDURE FOR OBTAINING 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-IL) PIPERIDIN-1-IL) -ETIL) -2-METHYL-6,7,8,9- TETRAHIDRO-4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONA. Expired - Fee Related ES2074966B1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ES09400252A ES2074966B1 (en) 1994-02-11 1994-02-11 PROCEDURE FOR OBTAINING 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-IL) PIPERIDIN-1-IL) -ETIL) -2-METHYL-6,7,8,9- TETRAHIDRO-4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONA.
GR950100035A GR1002344B (en) 1994-02-11 1995-02-01 A method for obtaining 3-{2-£4-(6-fluoro-benzo£D|isoxazol-3yl)piperidine -1-il|-ethyl}-2-methyl-6,7,8,9-tetrahudro-4H-pyrido£1,2-A|pyrimidine-4-one.
SK156-95A SK281752B6 (en) 1994-02-11 1995-02-07 Method for preparation of 3-{2-[4-(6-fluorine-benzo [d] isoxasol-3-yl)piperidine-1-yl]ethyl}-2-methyl-6,7,8,9- tetrahydro-4h-pyridol[1,2-a]pyrimidin-4-one and intermediates of this method
CZ1995329A CZ286398B6 (en) 1994-02-11 1995-02-08 Process for preparing 3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
IS4259A IS1766B (en) 1994-02-11 1995-02-08 Process for obtaining 3- {2- [4- (6-fluoro-benzo [D] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7,8,9- tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one
PT101654A PT101654B (en) 1994-02-11 1995-02-09 3- (6-FLUORO-BENZO- (D) -ISOXAZOL-3-YL) PIPERIDIN-1-YL} -ETHYL] -2-METHYL-6,7, 8,9-TETRAHYDRO-4H-PYRIDO- {1,2-A} PYRIMIDIN-4-ONA
NO950501A NO306022B1 (en) 1994-02-11 1995-02-09 Process for obtaining 3- {2- [4- (6-fluoro-benzo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7,8,9-tetrahydro -4H-pyrido [1,2-a] pyrimidin-4-one
EG11595A EG20877A (en) 1994-02-11 1995-02-09 A method for obtaining 3- (2- 4-6- fluoro - benzo (d) isoxazol -3- yl) piperidine 1-il) -ethyl) -2- methyl - 6,7,8-tetrahydro-4h-pyrido (1,2-a) pyrimidine -4- one
HU9500418A HU222110B1 (en) 1994-02-11 1995-02-10 Process for producing 3-{2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)piperidine-1-il]-ethyl}-2-methyl-6,7,8,9-tetrahydro-4h-pyrido[1,2-a]pyrimidine-4-one and intermediates
FI950579A FI110000B (en) 1994-02-11 1995-02-10 Process for obtaining 3- {2- [4- (6-fluoro-benzo [d] isoxazol-3-yl) piperidin-1-yl] -ethyl} -2-methyl-6,7,8,9-tetrahydro -4H-pyrido [1,2-a] pyrimidine-4-one
PL95307200A PL181420B1 (en) 1994-02-11 1995-02-10 Method of obtaining 3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4h-pyridil[1,2-a]pyrimidin-4-one and intermediate compounds
AT0024995A AT405401B (en) 1994-02-11 1995-02-10 PROCESS FOR THE PREPARATION OF 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-YL) PIPERIDINE-1-YL) -ETHYL) - 2-METHYL-6,7,8,9-TETRAHYDRO -4H- PYRIDO (1,2-A) PYRIMIDIN-4-ON
RU95101859/04A RU2123004C1 (en) 1994-02-11 1995-02-10 METHOD OF PREPARING 3-(2-[4-6-FLUOROBENZO [d] ISOXAZOL-3- YL] PIPERIDINE-1-Y) EHTYL-2-METHYL-6,7,8,9-TETRAHYDRY-4H- PYRIDO [1,2-a] PYRIMIDIN-4-ONE AND INTERMEDIATE COMPOUNDS FOR PREPARING THEREOF
KR1019950002516A KR100221108B1 (en) 1994-02-11 1995-02-11 3-2-[4-6--[d]-3--1-]--2--6789--4H-[12-a]-4-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09400252A ES2074966B1 (en) 1994-02-11 1994-02-11 PROCEDURE FOR OBTAINING 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-IL) PIPERIDIN-1-IL) -ETIL) -2-METHYL-6,7,8,9- TETRAHIDRO-4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONA.

Publications (2)

Publication Number Publication Date
ES2074966A1 true ES2074966A1 (en) 1995-09-16
ES2074966B1 ES2074966B1 (en) 1996-06-16

Family

ID=8285178

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09400252A Expired - Fee Related ES2074966B1 (en) 1994-02-11 1994-02-11 PROCEDURE FOR OBTAINING 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-IL) PIPERIDIN-1-IL) -ETIL) -2-METHYL-6,7,8,9- TETRAHIDRO-4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONA.

Country Status (14)

Country Link
KR (1) KR100221108B1 (en)
AT (1) AT405401B (en)
CZ (1) CZ286398B6 (en)
EG (1) EG20877A (en)
ES (1) ES2074966B1 (en)
FI (1) FI110000B (en)
GR (1) GR1002344B (en)
HU (1) HU222110B1 (en)
IS (1) IS1766B (en)
NO (1) NO306022B1 (en)
PL (1) PL181420B1 (en)
PT (1) PT101654B (en)
RU (1) RU2123004C1 (en)
SK (1) SK281752B6 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103237A1 (en) * 1995-04-12 1997-09-01 Ferrerinternacional S A New compound derived from chromene
ES2144355A1 (en) * 1997-12-30 2000-06-01 Ferrer Int 7- not (PIPERIDIN-1-YL)- PROPOXY -CHROMEN-4-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE
WO2001085731A1 (en) * 2000-05-05 2001-11-15 Rpg Life Sciences Limited A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one
US7202360B2 (en) 2002-10-18 2007-04-10 Hanmi Pharm Co., Ltd. Method for preparing risperidone
US7256195B2 (en) 2000-08-14 2007-08-14 Teva Pharmaceutical Industries Ltd. Preparation of risperidone
US7405298B2 (en) 2002-11-13 2008-07-29 Synthon Ip Inc. Process for making risperidone and intermediates therefor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5315336B2 (en) * 2007-04-19 2013-10-16 又欣 李 Novel compounds for the treatment of psychiatric disorders and their preparation and use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506705A1 (en) * 1981-11-12 1985-08-01 Hoechst Roussel Pharma 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles, a process for the preparation thereof, a pharmaceutical composition comprising the same, and their use as medicaments.
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0299349A2 (en) * 1987-07-13 1989-01-18 Hoechst-Roussel Pharmaceuticals Incorporated N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds, a process for their preparation and their use as medicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506705A1 (en) * 1981-11-12 1985-08-01 Hoechst Roussel Pharma 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles, a process for the preparation thereof, a pharmaceutical composition comprising the same, and their use as medicaments.
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
EP0299349A2 (en) * 1987-07-13 1989-01-18 Hoechst-Roussel Pharmaceuticals Incorporated N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds, a process for their preparation and their use as medicaments

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2103237A1 (en) * 1995-04-12 1997-09-01 Ferrerinternacional S A New compound derived from chromene
ES2144355A1 (en) * 1997-12-30 2000-06-01 Ferrer Int 7- not (PIPERIDIN-1-YL)- PROPOXY -CHROMEN-4-ONE DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE
WO2001085731A1 (en) * 2000-05-05 2001-11-15 Rpg Life Sciences Limited A PROCESS FOR THE PREPARATION OF ANTI-PSCHOTIC 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-one
US7256195B2 (en) 2000-08-14 2007-08-14 Teva Pharmaceutical Industries Ltd. Preparation of risperidone
US7202360B2 (en) 2002-10-18 2007-04-10 Hanmi Pharm Co., Ltd. Method for preparing risperidone
US7405298B2 (en) 2002-11-13 2008-07-29 Synthon Ip Inc. Process for making risperidone and intermediates therefor

Also Published As

Publication number Publication date
FI950579A0 (en) 1995-02-10
RU95101859A (en) 1997-03-20
HU9500418D0 (en) 1995-03-28
NO950501D0 (en) 1995-02-09
SK15695A3 (en) 1995-10-11
KR100221108B1 (en) 1999-09-15
PT101654A (en) 1995-09-12
PL307200A1 (en) 1995-08-21
CZ32995A3 (en) 1995-09-13
ATA24995A (en) 1998-12-15
SK281752B6 (en) 2001-07-10
EG20877A (en) 2000-05-31
ES2074966B1 (en) 1996-06-16
NO950501L (en) 1995-08-14
HUT70169A (en) 1995-09-28
AT405401B (en) 1999-08-25
CZ286398B6 (en) 2000-04-12
RU2123004C1 (en) 1998-12-10
PL181420B1 (en) 2001-07-31
KR950032196A (en) 1995-12-20
GR1002344B (en) 1996-05-24
HU222110B1 (en) 2003-04-28
NO306022B1 (en) 1999-09-06
FI950579A (en) 1995-08-12
IS1766B (en) 2001-03-15
FI110000B (en) 2002-11-15
IS4259A (en) 1995-08-12
PT101654B (en) 2002-01-30

Similar Documents

Publication Publication Date Title
FI893405A (en) Process for the preparation of quinolone compounds
GR3033439T3 (en) 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
IL117147A0 (en) Unsaturated hydroxyalkylquinoline acids and pharmaceutical compositions containing them
AU5581190A (en) Diarylstrylquinoline diacids
KR960703408A (en) [1,3,4] triazolo [1,5-a] pyridine ([1,3,4] TRIAZOLO [1,5-a] PYRIDINES USED AS INTERMEDIATE PRODUCTS FOR THE SYNTHESIS OF DYES)
ES2074966A1 (en) Process for obtaining 3-2-[4-(6-fluoro-benzo[d]isoxazol-3- yl)-piperidin-1-yl]-ethyl-2-methyl-6,7,8,9-tetrahydro-4H- pyrido-[1,2-a]pyrimidine-4-one
EP0424802A3 (en) Tricyclic quinoline antineoplastic agents
NO914003D0 (en) PROCEDURE FOR THE PREPARATION OF HYDROXYALKYLKINOLINETHER ACIDS
AU2001287996A1 (en) Process for the preparation of triphenodioxazine pigments
TW200510315A (en) Process for the prepatation of 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone
ES2036128A1 (en) 4-Imidazo 5-pyridin-8-yl 1,4-di:hydro-pyridine derivs. prepn.
ES2003196A6 (en) Di:hydro oxo-quinoline carboxylic acid deriv. prepn.
HUT47293A (en) Process for producing pyrimido-oxazine derivatives
JPS6470483A (en) Quinoline-3-carboxylic acid derivative
ES8400090A3 (en) Prepn. of coronary circulation stabilisers
WO2000034286A3 (en) Process for the preparation of pyrimidinone derivatives

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 20030305

FD2A Announcement of lapse in spain

Effective date: 20141120